Category: Approval/Launch Region: Asia · Japan Company: Solasia Pharma Kk

Japanese MHLW approves Solasias organoarsenic drug Darvias injection to treat relapsed or refractory PTCL

By, Admin 1 min read
Share
Japanese MHLW approves Solasias organoarsenic drug Darvias injection to treat relapsed or refractory PTCL
Solasia Pharma K.K., a specialty pharmaceutical company, announced that an organoarsenic drug

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!